Coral Laboratories Limited (BOM:524506)
India flag India · Delayed Price · Currency is INR
440.75
+8.20 (1.90%)
At close: Mar 9, 2026

Coral Laboratories Company Description

Coral Laboratories Limited manufactures and sells pharmaceutical formulations in India, Ethiopia, and internationally.

The company offers non-sterile products, including antibiotics/antibacterial, antifungal, gastro-intestinal drugs, antiemetic, analgesics/antipyretic/anti-inflammatory, antispasmodic, muscle relaxants, cough suppressant/expectorant, anticold, antiallergic, anti-asthmatic, cardiovascular medicines, anti-diabetic, anthelmentic, anti-protozoal/anti-amebic, antimalarial drugs, antipsychotic drugs, and thyroid products; topical, oral antiseptic, and calcium preparations; mouthwashes; nutritional, protein, and iron supplements; kits; appetizers; and other products.

It also provides sterile products, such as small volume liquid, cephalosporin, betalactam, and lyophilized injectables; eye, ear, and nose drops; nasal sprays and metered dose inhalers; and large volume parenteral.

In addition, the company offers various nutraceutical products, such as dietary supplements, herbal/phytochemicals, multivitamins, and nutrients, as well as OTC products.

Coral Laboratories Limited was incorporated in 1994 and is headquartered in Mumbai, India.

Coral Laboratories Limited
Country India
Founded 1994
Industry Pharmaceutical Preparations
Employees 197
CEO Girish Dhameja

Contact Details

Address:
#3B, Patanwala Industrial Estate
Mumbai, Gujarat 400086
India
Phone 91 22 2500 5245
Website corallab.com

Stock Details

Ticker Symbol 524506
Exchange Bombay Stock Exchange
Fiscal Year April - March
Reporting Currency INR
SIC Code 2834

Key Executives

Name Position
Girish Dhameja Chief Executive Officer
Sushma Kadkade Chief Financial Officer